AXSM Axsome Therapeutics Inc

Axsome Therapeutics Inc is a pharmaceutical company in the United States. It focusses on developing novel therapeutics for the redressal of diseases related to the central nervous system.

$53.65  -0.03 (-0.06%)
As of 07/26/2021 09:59:51 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/19/2015
Outstanding shares:  37,570,390
Average volume:  360,553
Market cap:   $2,099,433,393
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    05464T104
ISIN:        US05464T1043
Sedol:      BYZR4X4
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   20.94
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy